SEC
|
Vignola Mark J.
|
Chief Financial Officer
|
|
+4.8K
|
$4.44
|
+$21.27K
|
|
SEC
|
Yoon Seokho Bryan
|
COO and General Counsel
|
|
+4.8K
|
$4.44
|
+$21.27K
|
|
SEC
|
Vivo Capital Surplus Fund VIII, L.P.
|
N/A
|
|
-421K
|
$6.65
|
-$2.80M
|
|
SEC
|
Sundaram Senthil Vel
|
Chief Executive Officer
|
|
+2.1K
|
$1.41
|
+$2.98K
|
|
SEC
|
Vignola Mark J.
|
Chief Financial Officer
|
|
+10K
|
$1.41
|
+$14.10K
|
|
SEC
|
Yoon Seokho Bryan
|
COO and General Counsel
|
|
+10K
|
$1.41
|
+$14.10K
|
|
SEC
|
GORDON CARL L
|
N/A
|
|
+138K
|
$7.25
|
+$1.00M
|
|
SEC
|
Lu Hongbo
|
N/A
|
|
+759K
|
$7.25
|
+$5.50M
|
|
SEC
|
OrbiMed Genesis GP LLC
|
N/A
|
|
+138K
|
$7.25
|
+$1.00M
|
|
SEC
|
Vivo Capital Surplus Fund VIII, L.P.
|
N/A
|
|
+759K
|
$7.25
|
+$5.50M
|
|
SEC
|
Sundaram Senthil Vel
|
Chief Executive Officer
|
|
+3
|
$1.41
|
+$4.23
|
|
SEC
|
Vignola Mark J.
|
Chief Financial Officer
|
|
+3
|
$1.41
|
+$4.23
|
|
SEC
|
Yoon Seokho Bryan
|
COO and General Counsel
|
|
+3
|
$1.41
|
+$4.23
|
|
SEC
|
Oriental Spring Venture Ltd
|
N/A
|
|
-1.5M
|
$5.50
|
-$8.25M
|
|
SEC
|
Lu Hongbo
|
N/A
|
|
+600K
|
$3.60
|
+$2.16M
|
|
SEC
|
Vivo Capital Surplus Fund VIII, L.P.
|
N/A
|
|
+600K
|
$3.60
|
+$2.16M
|
|
SEC
|
GORDON CARL L
|
N/A
|
|
+3.7M
|
$2.42
|
+$8.93M
|
|
SEC
|
Lu Hongbo
|
N/A
|
|
+2.6M
|
$2.66
|
+$6.98M
|
|
SEC
|
OrbiMed Genesis GP LLC
|
N/A
|
|
+3.7M
|
$2.42
|
+$8.93M
|
|
SEC
|
Vivo Capital Surplus Fund VIII, L.P.
|
N/A
|
|
+5.2M
|
$2.66
|
+$13.96M
|
|
SEC
|
Sundaram Senthil Vel
|
Chief Executive Officer
|
|
+7.7K
|
$1.47
|
+$11.25K
|
|
SEC
|
Vignola Mark J.
|
Chief Financial Officer
|
|
+7.7K
|
$1.47
|
+$11.25K
|
|
SEC
|
Yoon Seokho Bryan
|
COO and General Counsel
|
|
+7.7K
|
$1.47
|
+$11.25K
|
|
SEC
|
Deerfield Mgmt L.P.
|
N/A
|
|
+2.4M
|
$17.00
|
+$40.49M
|
|
SEC
|
GORDON CARL L
|
N/A
|
|
+3.8M
|
$17.00
|
+$64.45M
|
|
SEC
|
OrbiMed Advisors III Ltd
|
N/A
|
|
+3.8M
|
$17.00
|
+$64.45M
|
|
SEC
|
Vivo Opportunity Fund, L.P.
|
N/A
|
|
+2.7M
|
$17.00
|
+$45.48M
|
|
SEC
|
RAKIB SHLOMO
|
N/A
|
|
-150K
|
$3.53
|
-$529.50K
|
|
SEC
|
RAKIB ZAKI DR
|
N/A
|
|
-150K
|
$3.53
|
-$529.50K
|
|
SEC
|
SCHAEPE CHRISTOPHER J
|
N/A
|
|
-2.8K
|
$6.90
|
-$19.32K
|
|
SEC
|
SCHAEPE CHRISTOPHER J
|
N/A
|
|
-5.4K
|
$6.84
|
-$36.94K
|
|
SEC
|
LUSTENADER CAROL W
|
N/A
|
|
-76K
|
$6.97
|
-$529.37K
|
|